Contineum Therapeutics (NasdaqGS:CTNM) 2025 Conference Transcript

Contineum Therapeutics (NasdaqGS:CTNM) 2025 Conference September 09, 2025 02:00 PM ET Company ParticipantsCharlie Moore - Senior Biotech AssociateCarmine Stengone - President and CEOCharlie MooreHave you figured out how, you know, like Admilparant?Nope.All right. Hello, everyone. My name is Charlie Moore. I'm a Senior Biotech Associate here at Baird, and I'm pleased to welcome here today Carmine Stengone from Contineum Therapeutics. He's the CEO, and he will be telling us more about his company and the asse ...